Replication Restriction of Influenza A(H5N1) Clade 2.3.4.4b Viruses by Human Immune Factor, 2023–2024
Emerging Infectious Diseases · 2025-01 · 31 (1)
DOI: 10.3201/eid3101.241236 ↗Kurz gefasst
Fachartikel in der Zeitschrift Emerging Infectious Diseases, 2025-01. Verfasst von Jakob Ankerhold und 4 weiteren Autor:innen. Hauptthemen laut MEDLINE: Virus Replication, Influenza A Virus, H5N1 Subtype, Influenza, Human, Myxovirus Resistance Proteins. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 10 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Zitieren
APA
Ankerhold, J., Kessler, S., Beer, M., Schwemmle, M., & Ciminski, K. (2025). Replication Restriction of Influenza A(H5N1) Clade 2.3.4.4b Viruses by Human Immune Factor, 2023–2024. Emerging Infectious Diseases, 31(1). https://doi.org/10.3201/eid3101.241236
Vancouver
Ankerhold J, Kessler S, Beer M, Schwemmle M, Ciminski K. Replication Restriction of Influenza A(H5N1) Clade 2.3.4.4b Viruses by Human Immune Factor, 2023–2024. Emerging Infectious Diseases. 2025;31(1). doi:10.3201/eid3101.241236
BibTeX
@article{Ankerhold2025,
author = {Ankerhold, Jakob and Kessler, Susanne and Beer, Martin and Schwemmle, Martin and Ciminski, Kevin},
title = {Replication Restriction of Influenza A(H5N1) Clade 2.3.4.4b Viruses by Human Immune Factor, 2023–2024},
journal = {Emerging Infectious Diseases},
year = {2025},
volume = {31},
number = {1},
doi = {10.3201/eid3101.241236}
}
EUVIMED